Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion type Assertion NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_head.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion description "[The early application of PGZ is able to prevent NNK-induced lung tumor development through maintaining the level of endogenous PPAR? ligands 15(S)-HETE and 13(S)-HODE and activation of PPAR?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_provenance.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion evidence source_evidence_literature NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_provenance.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion SIO_000772 22463586 NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_provenance.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion wasDerivedFrom befree-20150227 NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_provenance.
- NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_assertion wasGeneratedBy ECO_0000203 NP637375.RA2gTBcma6Jz-X_SVHDuCr3MTippgwE-nmlthrShF25B4130_provenance.